Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Hematologic Neoplasms 5Myelodysplastic Syndromes 4Tuberous Sclerosis 2Recurrence 2Primary Myelofibrosis 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Epilepsy 2Bronchiolitis Obliterans Syndrome 2Thyroid Neoplasms 1Solid Tumor 1Sarcoma 1Prostate Cancer Recurrent 1Non-Malignant Neoplasm 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Lymphangioleiomyomatosis 1Leukemia, Prolymphocytic 1Leukemia, Plasma Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1

Interventions

Sirolimus 2Therapeutic Touch 1Temozolomide 1Sulfasalazine 1Radiotherapy 1Memantine 1Medical Marijuana 1Magnetoencephalography 1Gabapentin 1Clinical Laboratory Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Epilepsy × Sirolimus × Clear all
NCT05104983 2026-01-22

TSC-STEPS

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
64 enrolled

Epilepsy, Tuberous Sclerosis

NCT05534672 2023-08-08

RaRE-TS

Children's Memorial Health Institute, Poland

Phase 3 Recruiting
200 enrolled

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡